Nonobese mice with nonalcoholic steatohepatitis fed on a choline-deficient, l-amino acid-defined, high-fat diet exhibit alterations in signaling pathways

FEBS Open Bio. 2021 Nov;11(11):2950-2965. doi: 10.1002/2211-5463.13272. Epub 2021 Sep 21.

Abstract

Nonalcoholic steatohepatitis (NASH) is often associated with obesity, but some patients develop NASH without obesity. The physiological processes by which nonobese patients develop NASH and cirrhosis have not yet been determined. Here, we analyzed the effects of dietary methionine content on NASH induced in mice fed on a choline-deficient, methionine-lowered, l-amino acid-defined high-fat diet (CDAHFD). CDAHFD with insufficient methionine induced insulin sensitivity and enhanced NASH pathology, but without obesity. In contrast, CDAHFD with sufficient methionine induced steatosis, and unlike CDAHFD with insufficient methionine, also induced obesity and insulin resistance. Gene profile analysis revealed that the disease severity in CDAHFD may partially be due to upregulation of the Rho family GTPases pathway and mitochondrial and nuclear receptor signal dysfunction. The signaling factors/pathways detected in this study may assist in future study of NASH regulation, especially its 'nonobese' subtype.

Keywords: Rho GTPases signaling; nonalcoholic steatohepatitis; ‘nonobese’ NASH subtype.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids
  • Animals
  • Choline / metabolism
  • Choline Deficiency / physiopathology
  • Diet, High-Fat / adverse effects
  • Disease Models, Animal
  • Lipid Metabolism
  • Liver / metabolism
  • Liver Cirrhosis / metabolism
  • Male
  • Methionine / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Non-alcoholic Fatty Liver Disease / physiopathology
  • Obesity / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*

Substances

  • Amino Acids
  • Methionine
  • Choline